BioCardia, Inc. — Director's Dealing 2016

Aug 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tiger X Medical, Inc. (CDOM)
CIK: 0000925741
Period of Report: 2016-08-11

Reporting Person: Rubin Steven D (Director, Interim CEO and Interim CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-11	Common Stock	A	200000	$0.00	Acquired	302822	Direct

Footnotes

F1: Pursuant to a Stock Award Agreement effective August 11, 2016 between Tiger X Medical, Inc. (the "Company") and the reporting person (the "Agreement"), this grant of restricted stock of the Company vests in full on August 11, 2017 (the "Vesting Date"), subject to the reporting person's continued service with the Company; provided, however, to the extent the reporting person's service with the Company is terminated for any reason within thirty (30) days prior to or upon a Change in Control (as defined in the Agreement) prior to the Vesting Date, this grant of restricted stock will immediately and automatically vest in full.